We support ministers in leading the nation’s health and social care to help people live more independent, healthier lives for longer.
The Committee is examining the relationship between leadership in the NHS and performance/productivity as well as patient safety. It will …
Oral Answers to Questions is a regularly scheduled appearance where the Secretary of State and junior minister will answer at the Dispatch Box questions from backbench MPs
Other Commons Chamber appearances can be:Westminster Hall debates are performed in response to backbench MPs or e-petitions asking for a Minister to address a detailed issue
Written Statements are made when a current event is not sufficiently significant to require an Oral Statement, but the House is required to be informed.
A Bill to Make provision about the supply of tobacco, vapes and other products, including provision prohibiting the sale of tobacco to people born on or after 1 January 2009; and to enable product requirements to be imposed in connection with tobacco, vapes and other products.
A Bill to make provision about health and social care.
This Bill received Royal Assent on 28th April 2022 and was enacted into law.
A Bill to confer power to amend or supplement the law relating to human medicines, veterinary medicines and medical devices; make provision about the enforcement of regulations, and the protection of health and safety, in relation to medical devices; and for connected purposes.
This Bill received Royal Assent on 11th February 2021 and was enacted into law.
A Bill to make provision in connection with coronavirus; and for connected purposes.
This Bill received Royal Assent on 25th March 2020 and was enacted into law.
To make provision regarding the funding of the health service in England in respect of each financial year until the financial year that ends with 31 March 2024.
This Bill received Royal Assent on 16th March 2020 and was enacted into law.
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
Prioritise teachers, school and childcare staff for Covid-19 vaccination
Gov Responded - 23 Feb 2021 Debated on - 11 Jan 2021Advice from the JCVI on the priority groups for a Covid-19 vaccine does not include school/childcare workers. This petition calls for these workers, who cannot distance or use PPE, to be kept safe at work by being put on the vaccine priority list when such a list is adopted into government policy.
We want the Government to commit to not rolling out any e-vaccination status/immunity passport to the British public. Such passports could be used to restrict the rights of people who have refused a Covid-19 vaccine, which would be unacceptable.
Prevent any restrictions on those who refuse a Covid-19 vaccination
Gov Responded - 11 Sep 2020 Debated on - 14 Dec 2020I want the Government to prevent any restrictions being placed on those who refuse to have any potential Covid-19 vaccine. This includes restrictions on travel, social events, such as concerts or sports. No restrictions whatsoever.
Commons Select Committees are a formally established cross-party group of backbench MPs tasked with holding a Government department to account.
At any time there will be number of ongoing investigations into the work of the Department, or issues which fall within the oversight of the Department. Witnesses can be summoned from within the Government and outside to assist in these inquiries.
Select Committee findings are reported to the Commons, printed, and published on the Parliament website. The government then usually has 60 days to reply to the committee's recommendations.
The Government is not consulting on the longstanding policy of single-sex hospital accommodation, as part of the NHS Constitution consultation. We are consulting on an update to the existing pledge on sleeping accommodation in hospitals, to reflect the legal position on the provision of same-sex services on which transgender patients can be offered separate accommodation, as a proportionate means to a legitimate aim. We are consulting on this in recognition of the concerns that patients may have about sharing hospital accommodation with patients of the opposite sex.
We are working with NHS England to grow the workforce by boosting recruitment, addressing the reasons why doctors leave the profession, and encouraging them to return to practice. Under the NHS Long Term Workforce Plan, the number of general practice training places will rise from 4,000 to 6,000 by 2031/32. The first 500 new places will be available from September 2025. NHS England has made available a number of recruitment and retention schemes, to boost the general practice workforce.
We are working with NHS England to grow the workforce by boosting recruitment, addressing the reasons why doctors leave the profession, and encouraging them to return to practice. Under the NHS Long Term Workforce Plan, the number of general practitioner training places will rise from 4,000 to 6,000 by 2031/32. The first 500 new places will be available from September 2025. NHS England has made available a number of recruitment schemes to boost the general practice workforce.
It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.
Each GP is required to provide services to meet the reasonable needs of their patients. There is no Government recommendation for how many patients a GP should have assigned, or the ratio of GPs or other practice staff to patients. The demands each patient places on their GP are different, and can be affected by many different factors, including rurality and patient demographics. It is necessary to consider the workforce for each practice as a whole, not only GPs, but also the range of health professionals available who are able to respond to the needs of their patients.
It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.
It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
It has not proved possible to reply to the hon Member in the time available before Dissolution.
It has not proved possible to reply to the hon Member in the time available before Dissolution.
It has not proved possible to reply to the hon Member in the time available before Dissolution.
It has not proved possible to respond to the hon. Member in the time available before Dissolution.
It has not proved possible to respond to the hon. Member in the time available before Dissolution.
It has not proved possible to respond to the hon. Member in the time available before Dissolution.
It has not proved possible to respond to the hon. Member in the time available before Dissolution.
It has not proved possible to reply to the hon Member in the time available before Dissolution.
It has not proved possible to respond to the hon. Member in the time available before Dissolution.
It has not proved possible to respond to the hon. Member in the time available before Dissolution.
It has not proved possible to reply to the hon Member in the time available before Dissolution.
Machine learning is in active use in the national patient safety learning system, known as the Learn from Patient Safety Events service, which has been rolled out across the National Health Service in England. The service provides a modern platform upon which technological advances such as machine learning can now operate. Named Entity Recognition is already aiding in the anonymisation of records, so that they can be used for learning activities without risk of identification of individuals.
Ongoing work is also being undertaken to explore how machine learning can support the analysis of data relating to patient safety events captured from across healthcare, and to look at how machine learning can identify new, emerging, and under recognised risks to patient safety. Future plans are also in place to enable support for the automated theming of unstructured free text, which will lay the foundations for targeted topic-specific improvement and guidance.
Current evidence suggests that whilst nicotine pouch use is low amongst adults, it is increasing, especially with the younger male audience. Nicotine products, such as nicotine pouches, are not currently subject to advertising restrictions.
The Tobacco and Vapes Bill proposed measures to prohibit the sale of tobacco to people born on or after 1 January 2009, as well as enabling product requirements to be imposed in connection with tobacco, vapes, and other products. However, the bill did not receive Parliamentary approval prior to the prorogation on 24 May 2024.
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
It is for local National Health Service organisations to choose which products and services they commission. We would expect local organisations to commission services which they deem to be effective and value for money.
A local Digital Technology Assessment Criteria (DTAC) assessment is required as part of the procurement process. It is expected that Kooth would only have been commissioned if the local NHS organisation had ensured it met baseline DTAC standards across technical assurance, data protection, clinical safety, interoperability, usability, and accessibility.
NHS England are reviewing the concerns raised by Members of Parliament and campaigners relating to Kooth.
The final report of the Infected Blood Inquiry describes the many failings of successive governments, including historic failings in the Department and its predecessor departments. The Department will study the report to make sure the lessons of Sir Brian’s inquiry are learned, and that these mistakes can never be repeated.
The Department proudly supports the Disability Confident Scheme, and has renewed its status as a Disability Confident employer. No single official works directly on the scheme, and in line with Civil Service guidance, we have moved away from standalone roles and teams to embed equality, diversity, and inclusion activities within existing human resource portfolios and roles. Activity to support the recruitment and retention of colleagues with a disability is undertaken across our recruitment, talent, and employee experience teams.
In the last calendar year, 11.3% of successful applicants applied under the Disability Confident Scheme. This is a slight increase from last year, at 10.9%. We additionally review our disability representation rates on a regular basis to monitor the impact of our recruitment practices and policy changes. We also have dedicated staff networks to support our disabled employees and celebrate achievements. Turnover of permanent employees who have declared they have a disability is currently approximately 6%, which is significantly lower than the average permanent staff turnover of colleagues who do not have a declared disability.
In 2023, we launched a new Workplace Adjustments policy, process, and passport. The new process is designed to ensure everyone in the Department can access the support they need as easily and quickly as possible via a person-centred approach that identifies and seeks to remove workplace barriers.
We also delivered several talent schemes that can assist in supporting the retention and development of disabled colleagues. This includes Beyond Boundaries, a 12-month programme for the Senior Executive Officer grade and below, to support candidates in reaching their full potential. As part of the programme, to support disability positive action, last year we ringfenced six job places out of 30, based on the proportionality of our disabled workforce, the People Survey, and recruitment data. We expect to take similar action this year.
In addition, the Future Leaders Scheme (FLS) is a 12-month accelerated development scheme for Grade 6 or 7 colleagues, who have the potential to progress to the Civil Service’s most senior and critical leadership roles. There is an option for those candidates who declare a disability or long-term health condition, or both, to enrol on the Disability Empowers Leadership Talent Association (DELTA) integrated scheme. In 2022, we had four candidates participate in DELTA out of the 21 successful FLS candidates, and two out of 26 in 2021, as per the data from the Cabinet Office. It should be noted that due to the sensitive nature of the programmes, not all participants are comfortable in being open about participation in DELTA, especially those with disabilities who have yet to disclose this to their colleagues or managers.
Finally, the Department’s mutual mentoring programme encourages underrepresented groups, including colleagues with disabilities, to mentor senior civil service colleagues to help increase the engagement and retention of underrepresented staff, and increase cultural intelligence in senior leaders.
There are no current plans to publish a national pathway for the elective care of all ophthalmology conditions.
Through the 2021 Drugs Strategy we are making the largest ever single increase in drug and alcohol treatment and recovery funding, with £780 million of additional investment. Of this, £532 million is being invested to rebuild local authority commissioned substance misuse treatment services in England, including alcohol treatment services. The Supplemental Substance Misuse Treatment and Recovery (SSMTR) Grant is the mechanism by which local authorities receive Drug Strategy funding. This is additional to the amounts invested through the Public Health Grant. The following table shows the SSMTR Grant and the Inpatient Detox (IPD) Grant allocations for the North East, in 2022/23, 2023/24, and 2024/25, as well as the total for those three years:
| 2022/23 | 2023/24 | 2024/25 | Total |
SSMTR | £7,051,992 | £13,677,970 | £24,787,253 | £45,517,215 |
IPD | £727,295 | £727,295 | £727,295 | £2,181,885 |
The Department is also providing £1,157,212 in funding to three local authorities in the North East, specifically Middlesborough, Newcastle, and Durham, to improve access to drug and alcohol treatment services for people who sleep rough, or who are at risk of sleeping rough. Under the NHS Long Term Plan, between 2019/20 and 2024/25, NHS England has made over £30 million available to local healthcare systems to facilitate the delivery of specialist Alcohol Care Teams in hospitals in the areas with the highest rates of alcohol harm and socioeconomic deprivation.
The Office for Health Improvements and Disparities is developing comprehensive United Kingdom guidelines for the clinical management of harmful drinking and alcohol dependence. The overarching aim of the guideline is to develop a clear consensus on good practice, and improve the quality of treatment and support.
Through the 2021 Drugs Strategy we are making the largest ever single increase in drug and alcohol treatment and recovery funding, with £780 million of additional investment. Of this, £532 million is being invested to rebuild local authority commissioned substance misuse treatment services in England, including alcohol treatment services. The Supplemental Substance Misuse Treatment and Recovery (SSMTR) Grant is the mechanism by which local authorities receive Drug Strategy funding. This is additional to the amounts invested through the Public Health Grant. The following table shows the SSMTR Grant and the Inpatient Detox (IPD) Grant allocations for the North East, in 2022/23, 2023/24, and 2024/25, as well as the total for those three years:
| 2022/23 | 2023/24 | 2024/25 | Total |
SSMTR | £7,051,992 | £13,677,970 | £24,787,253 | £45,517,215 |
IPD | £727,295 | £727,295 | £727,295 | £2,181,885 |
The Department is also providing £1,157,212 in funding to three local authorities in the North East, specifically Middlesborough, Newcastle, and Durham, to improve access to drug and alcohol treatment services for people who sleep rough, or who are at risk of sleeping rough. Under the NHS Long Term Plan, between 2019/20 and 2024/25, NHS England has made over £30 million available to local healthcare systems to facilitate the delivery of specialist Alcohol Care Teams in hospitals in the areas with the highest rates of alcohol harm and socioeconomic deprivation.
The Office for Health Improvements and Disparities is developing comprehensive United Kingdom guidelines for the clinical management of harmful drinking and alcohol dependence. The overarching aim of the guideline is to develop a clear consensus on good practice, and improve the quality of treatment and support.
Excess deaths are the difference between the number of registered deaths and the number expected based on previous trends. Weekly estimates of excess deaths are published by the Office for National Statistics (ONS). Its latest data shows that for the years 2020 to 2022, there were an estimated 151,506 estimated excess deaths in England.
It is likely that deaths from COVID-19 were a large driver of excess deaths in the peak pandemic periods. Deaths were above the expected level for most of the second half of 2021, and from March 2022 until the summer of 2023; however, deaths have been below the expected level for most weeks since then.
The drivers of excess deaths are not fully understood, and the excess is likely to be the net effect of many complex and potentially related factors. The attribution of excess deaths to these factors is complex and beyond the scope of the ONS methodology. The UK Health Security Agency has estimated the excess deaths due to acute factors, such as heatwaves, cold snaps, COVID-19 and influenza.
Excess deaths are the difference between the number of registered deaths and the number expected based on previous trends. Weekly estimates of excess deaths are published by the Office for National Statistics (ONS). Its latest data shows that for the years 2020 to 2022, there were an estimated 151,506 estimated excess deaths in England.
It is likely that deaths from COVID-19 were a large driver of excess deaths in the peak pandemic periods. Deaths were above the expected level for most of the second half of 2021, and from March 2022 until the summer of 2023; however, deaths have been below the expected level for most weeks since then.
The drivers of excess deaths are not fully understood, and the excess is likely to be the net effect of many complex and potentially related factors. The attribution of excess deaths to these factors is complex and beyond the scope of the ONS methodology. The UK Health Security Agency has estimated the excess deaths due to acute factors, such as heatwaves, cold snaps, COVID-19 and influenza.
It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.
It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.
It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.
A review announced by the Government in December 2023 is currently underway to assess the operation and enforcement of the statutory duty of candour. The process includes gathering evidence from National Health Service staff and health service providers via a Call for Evidence, which is currently live, and is due to close on 29 May 2024. The Care Quality Commission has provided figures on the number of fixed penalty notices issued to providers for failure to comply with the duty, since it was introduced in 2014. The following table shows the number if fixed penalty notices issued each year from 2014 to 2023:
Year | Fixed penalty notice |
2014 | 0 |
2015 | 0 |
2016 | 0 |
2017 | 0 |
2018 | 0 |
2019 | 0 |
2020 | 0 |
2021 | 3 |
2022 | 1 |
2023 | 0 |
The Department has made no assessment of the impact of vacancy rates and of frontline social care and support staff turnover on the quality of care that those in receipt of social care receive, or on the ability of social care providers to deliver high quality care.
NHS England holds several data sources covering alcohol use for people aged under 18 years old, including the Smoking, Drinking and Drug Use among Young People survey. This data is collected every two years, and the next survey report is due Autumn 2024, and will include 2023 survey data.
The guidance from England’s Chief Medical Officer for healthcare professionals is clear, an alcohol-free childhood is the healthiest and best option. The Department promotes this through online platforms such as the NHS.UK website, and the Talk to FRANK online resource. Local authorities promote these guidelines as part of their public health duties.
Alcohol or drug dependence is rare in children and young people under the age of 18 years old, although they may be drinking problematically. For those that do need support, the Department has allocated £532 million of additional funding through to 2024/25 to support improvements in treatment, including facilitating 5,000 more young people into age-appropriate alcohol and drug treatment.
The Government has made up to £8.6 billion available in additional funding over 2023/24 and 2024/25, to support adult social care and discharge. This funding has enabled local authorities to buy more care packages, helped people leave hospital on time, improved workforce recruitment and retention, and reduced waiting times for care. The Government regularly meets with the Local Government Association and other representatives from the sector, to understand the pressures facing them.
Funding plans for 2025/26 will be developed as part of the next Spending Review. We will continue to work closely with local authorities and the adult social care sector to understand what the impact of cost and demand pressures will be on service delivery, and to support them in responding to these pressures.
75% of the four general practice locations in Enfield North are currently rated by the Care Quality Commission as Good overall. One further general practice surgery in Enfield North does not yet have a rating.
The Government’s vision, as set out in The Best Start for Life: A Vision for the 1,001 Critical Days, is that every parent and carer has access to high quality infant feeding services. Through the Family Hubs and Start for Life Programme, we are investing £50 million to enable 75 participating local authorities to design and deliver a blended offer of infant feeding support. The investment is being used to increase the range of advice and support available, including recruiting and training staff to improve workforce capacity and capability.
The NHS Long Term Workforce Plan sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. The Government is backing the plan with over £2.4 billion over the next five years to fund additional education and training places.
Current evidence suggests that whilst nicotine pouch use is low amongst adults, it is increasing, especially with the younger male audience.
Current evidence suggests that whilst nicotine pouch use is low amongst adults, it is increasing, especially with the younger male audience.
Whilst the Department will not make a specific estimate, the following link shows the number of diagnoses of bladder cancer in England for 2019 and 2020, the most recent years for which NHS Digital holds publicly available data:
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Practices are able to provide Directed Enhanced Services and Enhanced Services by opting in, and will receive payment for these services separately to global sum payments. As commissioners of primary care, integrated care boards are responsible for commissioning Local Enhanced Services, which are not agreed nationally and can vary in scope and funding to fit local needs.
Combined treatment for glaucoma and cataracts can already be considered when clinically appropriate, taking into account the patient’s wishes and the best available evidence. However, glaucoma is a chronic condition that requires long-term management and monitoring. For patient safety, all glaucoma or ocular hypertension surgery should be performed within units that are providing the full range of services, including diagnosing, treating, and monitoring patients. This also includes offering a full range of medical and surgical treatments that can include drops, laser treatments, and a full range of surgical procedures. This ensures that patients receive the right care, appropriate for the stage and type of glaucoma, and that inappropriate surgical interventions are not undertaken that compromise the long-term management of the patient’s condition.
Combined treatment for glaucoma and cataracts can already be considered when clinically appropriate, taking into account the patient’s wishes and the best available evidence. However, glaucoma is a chronic condition that requires long-term management and monitoring. For patient safety, all glaucoma or ocular hypertension surgery should be performed within units that are providing the full range of services, including diagnosing, treating, and monitoring patients. This also includes offering a full range of medical and surgical treatments that can include drops, laser treatments, and a full range of surgical procedures. This ensures that patients receive the right care, appropriate for the stage and type of glaucoma, and that inappropriate surgical interventions are not undertaken that compromise the long-term management of the patient’s condition.